As an endocrinologist, it’s important to stay up to date on the management of bone disease and parathyroid disorders, particularly with an increasingly older population that is at a higher risk for bone loss, osteoporosis, and fractures. Discover the top research and clinical treatments, healthcare disparities and cutting-edge therapeutics in bone disease and parathyroid care, with our course, Bone and Parathyroid Strategies for Endocrinologists.
Take your Bone and Parathyroid knowledge to the next level! This collection of lectures features the most recent and relevant topics in the field of Endocrinology. This online course contains video lectures, assessment questions, and the opportunity for CME and MOC!
Starts 7/21/2022 | Expires 7/21/2023
- Disease State Network Year-in-Review: Bone - Robert Wermers, MD, FACE; Jad Sfeir, MD, MS, FACP
- Healthcare Disparities in Metabolic Bone Disease - Nicole Wright, PhD, MPH
- Osteoporosis Conundrums - Eligayehu Abate, MD; Vin Tangpricha, MD, PhD, FACE; Albert Shieh, MD
- Parathyroid Disease: A 2022 Update
- Phosphatonins: From Discovery to Therapeutics - Rajiv Kumar, MD
Upon completion of the activity, participants should be able to:
- Discuss Updated Guidelines and Management of Persistent and Recurrent Hyperparathyroidism
- Quantify racial differences in osteoporosis and fragility fractures
- Evaluate and manage transplant related bone disorders
- Discuss approaches in screening and diagnosis of low bone density in transgender people
- Discuss physiology and pathophysiology and the utility of antibodies directed against fibroblast growth factor 23
Robert A. Wermers, MD, FACE
Jad Sfeir, MD, MS, FACP
Nicole C. Wright, PhD, MPH
Ejigayehu G. Abate, MD
Vin Tangpricha, MD, PhD, FACE
Albert Shieh, MD
Rajiv Kumar, MD
This educational initiative is intended for Endocrinologists.
The American College of Endocrinology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Endocrinology designates this enduring activity for a maximum of 5.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.75 MOC Medical Knowledge point(s) in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC point(s) equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.
Disclosures/Conflicts of Interest
In accordance with the ACCME Standards for Commercial Support, The American Association of Clinical Endocrinology (AACE) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. AACE resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, AACE seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. AACE is committed to providing learners with high-quality CME.
Activity Staff Disclosures
The planners, reviewers, editors, staff, CME committee, and other members at the American Association of Clinical Endocrinology who control content have no relevant financial relationships to disclose.
|Robert||A.||Wermers||MD, FACE||Professor of Medicine Mayo Clinic College of Medicine and Consultant and Chair Division of Endocrinology, Diabetes, Metabolism and Nutrition Mayo Clinic Rochester||Mayo Clinic College of Medicine; Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic||Speaker||Nothing to disclose|
|Jad||Sfeir||MD, MS, FACP||Assistant Professor of Medicine||Mayo Clinic||Speaker||Nothing to disclose|
|Nicole||C.||Wright||PhD, MPH||Associate Professor||University of Alabama at Birmingham||Speaker||Nothing to disclose|
|Gina||Woods||MD||Associate Clinical Professor||University of California, San Diego||Moderator||Nothing to disclose|
|Ejigayehu||G.||Abate||MD||Clinical Endocrinologist||Mayo Clinic Florida||Speaker||() :|
|Jennifer||Kelly||DO, FACE, CCD||Endocrinologist||University of Vermont Medical Center||Moderator||Nothing to disclose|
|Vin||Tangpricha||MD, PhD, FACE||Professor of Medicine||Emory University School of Medicine||Speaker||Nothing to disclose|
|Albert||Shieh||MD||University of California, Los Angeles||Speaker||Nothing to disclose|
Disclosure of Unlabeled Use
AACE requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. AACE does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.
The American Association of Clinical presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The American Association of Clinical Endocrinology assumes no liability for the information herein.